FORM 1 - Individual Substantial Shareholder Notice
Form Serial Number
:
IS20260703E00120
1.
Date of relevant event
:
29/06/2026
(dd/mm/yyyy)
2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later)
:
(dd/mm/yyyy)
3.
Stock code
:
09637
4.
Name of listed corporation
:
Alebund Pharmaceuticals (Jiangsu) Ltd. - B - H Shares
5.
Class of shares
:
H Shares
6.
Number of issued shares in class
:
227,122,189
7.
Name of substantial shareholder (English) as printed on HKID Card/Passport
:
(
Surname
)
Shi
(
Other names
)
Yi
10.
Name of substantial shareholder (Chinese)
:
施毅
11.
Chinese Character Code as printed on HKID Card
:
14.
Details of relevant event
:
Brief description of relevant event
Capacity in which shares were/are held
Number of shares bought/sold or involved
Currency of transaction
On Exchange
Off Exchange
Before relevant event
After relevant event
Highest price (per share)
Average price (per share)
Average consideration (per share)
Nature of consideration
Long position
1101
The percentage level of your interest in the shares has increased because:
you purchased the shares
2201
Interest of corporation controlled by you
2201
Interest of corporation controlled by you
450,000
HKD
46.0000
45.0615
Short position
15.
Total shares immediately before the relevant event
:
Total number of shares
Percentage figure (%)
Long position
15,897,290
6.99
16.
Total shares immediately after the relevant event
:
Total number of shares
Percentage figure (%)
Long position
16,347,290
7.20
17.
Capacity in which interests disclosed in Box 16 are held
:
Capacity code
Number of shares
2201
Interest of corporation controlled by you
Long position
16,347,290
18.
Further information in respect of derivative interests
:
Derivatives code
Number of shares
19.
Further information in relation to interests of children under 18 and/or spouse
:
Child/Spouse
Name of child/spouse
Number of shares
20.
Further information in relation to interests of corporations controlled by substantial shareholder
:
Name of controlled corporation
Address and place of incorporation
Name of controlling shareholder
% control
Direct interest (Y/N)
Number of shares
LAV Corporate IV GP, Ltd.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
Shi Yi
100.00
N
Long position
10,841,387
LAV GP IV, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV Corporate IV GP, Ltd.
100.00
N
Long position
10,841,387
LAV Biosciences Fund IV, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV GP IV, L.P.
100.00
N
Long position
10,841,387
LAV Delta Limited
Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)
LAV Biosciences Fund IV, L.P.
100.00
Y
Long position
10,841,387
LAV Corporate VI GP, Ltd.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
Shi Yi
100.00
N
Long position
3,991,115
LAV GP VI, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV Corporate VI GP, Ltd.
100.00
N
Long position
3,991,115
LAV Fund VI, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV GP VI, L.P.
100.00
N
Long position
3,991,115
LAV Orchid Limited
Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)
LAV Fund VI, L.P.
100.00
Y
Long position
3,097,755
LAV Star Limited
Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)
LAV Fund VI, L.P.
100.00
Y
Long position
893,360
LAV Corporate VI GP Opportunities, Ltd.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
Shi Yi
100.00
N
Long position
1,118,108
LAV GP VI Opportunities, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV Corporate VI GP Opportunities, Ltd.
100.00
N
Long position
1,118,108
LAV Fund VI Opportunities, L.P.
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV GP VI Opportunities, L.P.
100.00
N
Long position
1,118,108
LAV Efficacy Limited
Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)
LAV Fund VI Opportunities, L.P.
100.00
Y
Long position
224,748
LAV Star Opportunities Limited
Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)
LAV Fund VI Opportunities, L.P.
100.00
Y
Long position
893,360
LAV Public Equity Master Fund
190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)
LAV Asset Management (Hong Kong) Limited
100.00
Y
Long position
396,680
LAV Asset Management (Hong Kong) Limited
22nd Floor, Tai Yau Building, 181 Johnston Road, Wan Chai (Hong Kong)
Shi Yi
100.00
Y
Long position
16,347,290
21.
Further information in relation to interests held by substantial shareholder jointly with another person
:
Name of joint shareholder
Address
Number of shares
22.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust
:
Names of trust
Address
Status code
Number of shares
23.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required)
:
Names of other parties
Address
Number of shares
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
24.
Supplementary information
:
On June 29, 2026 (trade date), LAV Star Limited and LAV Star Opportunities Limited each purchased 200,000 H Shares of Alebund Pharmaceuticals (Jiangsu) Limited, while LAV Public Equity Master Fund purchased 50,000 H Shares. The settlement date for all transactions is July 2, 2026.
25.
Log/Serial Number of the previous form
:
26.
Number of concert party document(s) under section 317 attached/uploaded
:
Date of filing this Form 1
:
03/07/2026
(dd/mm/yyyy)